Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.53 |
| ▸ | MMP2 | P08253 | 9/20 | 0.53 |
| ▸ | MMP1 | P03956 | 5/20 | 0.53 |
| ▸ | MMP3 | P08254 | 4/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.49 |
| ▸ | FCER2 | P06734 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.48 |
| ▸ | PTPRA | P18433 | 1/20 | 0.48 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.48 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.48 |
| ▸ | CCKBR | P32239 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11569232 | 0.99 | PTPN1 (0.52) | PTPN1MMP2MMP1MMP3OPRM1 | |
| Hydrochloric Acid SCHEMBL11571613 | 0.92 | HDAC3 (0.50) | PTPN1MMP2MMP1MMP3FCER2 | |
| SCHEMBL19891256 | 0.89 | MMP2 (0.55) | MMP2MMP1MMP3CNR1CNR2 | |
| SCHEMBL18333007 | 0.85 | HDAC3 (0.58) | MMP1FCER2CNR1CNR2CTSL | |
| SCHEMBL29351192 | 0.85 | CCKBR (0.51) | CCKBR | |
| SCHEMBL30037369 | 0.85 | CCKBR (0.68) | OPRD1CCKBR | |
| Hydrochloric Acid SCHEMBL11569026 | 0.84 | CCKBR (0.51) | CCKBR | |
| SCHEMBL30887338 | 0.84 | MME (0.50) | PTPN1MMP2OPRD1CCKBR | |
| SCHEMBL30973624 | 0.84 | MME (0.64) | OPRM1OPRD1 | |
| SCHEMBL8583007 | 0.84 | MME (0.64) | OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12049518-B2 | Pharmacokinetics and cholecystokinin-2 receptor (CCK2R) targeting for diagnosis and therapy | MEDIZINISCHE UNIVERSITÄT INNSBRUCK (AT) | 2024-07-30 | — | — | US | disclosed |
| EP-4251213-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | ITM Solucin GmbH (DE) | 2023-10-04 | — | — | EP | disclosed |
| EP-4065176-A1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | ITM Isotope Technologies Munich SE (DE) | 2022-10-05 | — | — | EP | disclosed |
| WO-2022112323-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | ITM SOLUCIN GMBH (DE) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022111800-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | ITM SOLUCIN GMBH (DE) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022096673-A1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | ITM Isotopen Technologien München AG (DE) | 2022-05-12 | — | — | WO | disclosed |
| WO-2022096103-A1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | ITM Isotopen Technologien München AG (DE) | 2022-05-12 | — | — | WO | disclosed |